This is a conversation to discuss to what degree the EU is pulling its weight in its progression of alternative proteins. Is it showing leadership - in market growth, consumer adoption, investment, and innovation. What are the barriers to growth, i.e. does inconsistent regulation and political signals risk undermining this progress. Does Europe need more unified, forward-thinking strategies to maintain and expand its leadership as the sector matures. What should Europe be proud of?